Please note, endo sessions has been updated to remove some site content from past Endocrine Society programs.
If you have any questions please contact [email protected].
Search:
Search for text in:
separate each search
term with a space
term with a space
Multiple terms:
Quick Links:
Additional Search Filters:
Access:
Availability:
Showing session: reset
Emerging Endocrine Therapies Across the Lifespan
| Browse by: | Sort by: |
Chair
David D'Alessio, MD
Duke University School of Medicine, Durham, NC
Persistent and Stable Growth Promoting Effects of Vosoritide in Children With Achondroplasia for up to 2 Years: Results From the Ongoing Phase 3 Extension Study
Ravi Savarirayan, MD
Murdoch Children’s Research Institute, Royal Children’s Hospital, University of Melbourne, Parkville, Australia
Audience Q&A
Melita Irving, MD
Evelina Childrens Hospital, Guys & St Thomas Trust, London, United Kingdom
Effects of Setmelanotide in Patients With POMC, PCSK1, or LEPR Heterozygous Deficiency Obesity in a Phase 2 Study
Sadaf Farooqi, MD, PhD
Wellcome-MRC Institute of Metabolic Science and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom
Audience Q&A
Safety Evaluation of the Omnipod® 5 Automated Insulin Delivery System Over Three Months of Use in Adults and Adolescents With Type 1 Diabetes (T1D)
Sue Brown, MD
University of Virginia, Charlottesville, VA
Audience Q&A
Primary Results From MATCH: A Randomised Controlled Trial in Primary Aldosteronism
Xilin Wu, BA MBBS MRCP(London)
Queen Mary University of London, London, United Kingdom
Audience Q&A
Available
